From October 1, 2023 to February 8, 2024, the company has repurchased 194,554 shares, representing 0.12% for CNY 20.06 million. With this, the company has completed the repurchase of 496,600 shares, representing 0.32% for CNY 49.98 million under the buyback announced on August 11, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
119.3 CNY | +0.40% | -5.67% | -5.27% |
22/04 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
22/04 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.27% | 2.58B | |
+0.92% | 29.67B | |
+19.34% | 24.65B | |
+5.34% | 11.06B | |
+16.80% | 5.37B | |
+20.52% | 4.52B | |
-5.20% | 3.86B | |
+1.90% | 3.4B | |
+1.25% | 3.02B | |
+27.67% | 2.84B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Tranche Update on Anhui Huaheng Biotechnology Co., Ltd.'s Equity Buyback Plan announced on August 11, 2023.